Additionally, the same study indicated that IgG from ATLL patients can decrease the frequency of IL-4-producing CD4+ T cells, reduce the frequency of IFN-γ-producing γδT cells, and lower the frequency of IL-10-producing B cells. The gene discussed is IFNG; the disease is adult T-cell leukemia/lymphoma.